- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03606785
Evaluation of the Efficacy and Safety of Single Dose Tranexamic Acid in Reducing Blood Loss During Colorectal Cancer Surgery
A total of 46 patients scheduled for explorative laparotomy with the aim of radical debulking surgery for colorectal cancer will be randomized into two equal groups one will receive tranexamic acid and one placebo.
The TA group will receive an intravenous bolus of (10 mg/kg) in 100 ml of normal saline over 20 minutes after induction of anesthesia and before surgical incision. In the control group, patients will receive a placebo of 100 mL 0.9% normal saline. The primary endpoint is reduction in blood loss, while the secondary endpoint was the number of patients needing transfusion and occurrence of postoperative thrombotic complications (myocardial infarction, stroke, pulmonary embolism, renal failure, or bowel infarction) within 30 days after surgery.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- NCI, Cairo university
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria
- ASA 1 and ASA 2 patients scheduled for colorectal cancer surgery.
- Age above 18 years & less than 65 years.
Exclusion criteria:
- Thrombophilia or any bleeding disorder.
- Previous or active thromboembolic disease.
- Family history of thromboembolism.
- Known Allergy to TA.
- Liver dysfunction.
- Preexisting renal dysfunction (serum creatinine >1.2 mg/dL).
- Coronary stent insertion within a year prior to operation.
- Cardiovascular problem (e.g., myocardial infarction, atrial fibrillation, angina, heart failure),
- Lifelong warfarin therapy for thromboembolism prophylaxis.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: placebo group
|
patients will receive a placebo of 100 mL 0.9% normal saline
|
Active Comparator: tranexamic acid group
|
The TA group will receive an intravenous bolus of (10 mg/kg) in 100 ml of normal saline over 20 minutes after induction of anesthesia and before surgical incision
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
reduction in blood loss
Time Frame: 1 month
|
Blood loss will be calculated (volume estimated as the blood remaining in sponges and drapes and the volume in suction bottles during surgery).The amount of drained blood will be measured in 1st 24 hours.
|
1 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Neoplasms
- Neoplasms by Site
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Colonic Diseases
- Intestinal Diseases
- Intestinal Neoplasms
- Rectal Diseases
- Colorectal Neoplasms
- Molecular Mechanisms of Pharmacological Action
- Fibrin Modulating Agents
- Antifibrinolytic Agents
- Hemostatics
- Coagulants
- Tranexamic Acid
Other Study ID Numbers
- 201617010.2P
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Surgery
-
Medical University of South CarolinaCompletedColorectal Surgery | Hepatobiliary SurgeryUnited States
-
Gulhane School of MedicineUniversity Hospital, Ghent; Szeged University; University Clinical Centre of... and other collaboratorsCompletedColorectal Disorders | Colorectal SurgeryTurkey
-
York Teaching Hospitals NHS Foundation TrustCompletedColorectal Surgery | Major Abdominal SurgeryUnited Kingdom
-
IHU StrasbourgRecruitingColorectal SurgeryFrance
-
Indiana UniversityCompletedColorectal SurgeryUnited States
-
Wake Forest University Health SciencesWithdrawnColorectal Surgery
-
University of Massachusetts, WorcesterCompleted
-
Helsinki University Central HospitalActive, not recruiting
-
Children's Hospital Medical Center, CincinnatiTerminated
-
York Teaching Hospitals NHS Foundation TrustTerminatedColorectal SurgeryUnited Kingdom
Clinical Trials on Tranexamic Acid Injection
-
Kafrelsheikh UniversityRecruitingNephrolithiasis | Renal StonesEgypt
-
University of LiegeCompletedArthroplasty Complications | Hemorrhage Postoperative | Total Blood LossBelgium
-
Lawrence Charles HookeyQueen's UniversityCompleted
-
Indonesia UniversityCompleted
-
Dow University of Health SciencesCompletedCesarean Section Complications | Postpartum Hemorrhage | Obstetric Anesthesia ProblemsPakistan
-
Shahid Gangalal National Heart CentreCompleted
-
Meir Medical CenterUnknown
-
Daniel Nishijima, MD, MASPediatric Emergency Care Applied Research NetworkNot yet recruitingHemorrhage | Brain Injuries, Traumatic | Trauma Injury | Wounds and Injury
-
Indonesia UniversitySuspended
-
Tengzhou Central People's HospitalCompleted